Keywords: genasense, ph, iii, trial, progressing, target, drug

Genasense Ph III trial progressing on target

Article | 13 October 2008

Print This

US drug developer Genta has reported encouraging interim data from an ongoing Phase III trial of Genasense (oblimersen sodium) Injection, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in